Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Animal models in virus research: their utility and limitations.

Louz D, Bergmans HE, Loos BP, Hoeben RC.

Crit Rev Microbiol. 2013 Nov;39(4):325-61. doi: 10.3109/1040841X.2012.711740. Epub 2012 Sep 14. Review.

PMID:
22978742
2.

Studies on influenza virus transmission between ferrets: the public health risks revisited.

Fouchier RA.

MBio. 2015 Jan 23;6(1). pii: e02560-14. doi: 10.1128/mBio.02560-14. No abstract available.

3.

Reply to "Studies on influenza virus transmission between ferrets: the public health risks revisited".

Lipsitch M, Inglesby TV.

MBio. 2015 Jan 23;6(1). pii: e00041-15. doi: 10.1128/mBio.00041-15. No abstract available.

4.

Reply to "Comments on Fouchier's calculation of risk and elapsed time for escape of a laboratory-acquired infection from his laboratory".

Fouchier RA.

MBio. 2015 Apr 14;6(2). pii: e00407-15. doi: 10.1128/mBio.00407-15. No abstract available.

5.

Comments on Fouchier's calculation of risk and elapsed time for escape of a laboratory-acquired infection from his laboratory.

Klotz LC.

MBio. 2015 Apr 14;6(2). pii: e00268-15. doi: 10.1128/mBio.00268-15. No abstract available.

6.

Moratorium on research intended to create novel potential pandemic pathogens.

Lipsitch M, Inglesby TV.

MBio. 2014 Dec 12;5(6). pii: e02366-14. doi: 10.1128/mBio.02366-14. No abstract available. Erratum in: MBio. 2015;6(1). pii: e02534-14. doi: 10.1128/mBio.02534-14.

7.

Ferret models of viral pathogenesis.

Enkirch T, von Messling V.

Virology. 2015 May;479-480:259-70. doi: 10.1016/j.virol.2015.03.017. Epub 2015 Mar 26. Review.

8.

Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1.

Zhu Z, Prabakaran P, Chen W, Broder CC, Gong R, Dimitrov DS.

Virol Sin. 2013 Apr;28(2):71-80. doi: 10.1007/s12250-013-3313-x. Epub 2013 Apr 11. Review.

PMID:
23575729
9.

Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections.

Okabayashi T, Kariwa H, Yokota S, Iki S, Indoh T, Yokosawa N, Takashima I, Tsutsumi H, Fujii N.

J Med Virol. 2006 Apr;78(4):417-24.

PMID:
16482545
10.

Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates.

Wu D, Tu C, Xin C, Xuan H, Meng Q, Liu Y, Yu Y, Guan Y, Jiang Y, Yin X, Crameri G, Wang M, Li C, Liu S, Liao M, Feng L, Xiang H, Sun J, Chen J, Sun Y, Gu S, Liu N, Fu D, Eaton BT, Wang LF, Kong X.

J Virol. 2005 Feb;79(4):2620-5.

11.

[Recent developments in SARS vaccine studies].

Ruh E.

Mikrobiyol Bul. 2010 Jul;44(3):505-17. Review. Turkish.

PMID:
21064002
12.

Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.

Jaume M, Yip MS, Cheung CY, Leung HL, Li PH, Kien F, Dutry I, Callendret B, Escriou N, Altmeyer R, Nal B, Daëron M, Bruzzone R, Peiris JS.

J Virol. 2011 Oct;85(20):10582-97. doi: 10.1128/JVI.00671-11. Epub 2011 Jul 20.

13.

Influenza A virus transmission: contributing factors and clinical implications.

Belser JA, Maines TR, Tumpey TM, Katz JM.

Expert Rev Mol Med. 2010 Dec 9;12:e39. doi: 10.1017/S1462399410001705. Review.

PMID:
21144091
14.

The ferret as a model organism to study influenza A virus infection.

Belser JA, Katz JM, Tumpey TM.

Dis Model Mech. 2011 Sep;4(5):575-9. doi: 10.1242/dmm.007823. Epub 2011 Aug 2. Review.

15.

Control of human viral infections by natural killer cells.

Jost S, Altfeld M.

Annu Rev Immunol. 2013;31:163-94. doi: 10.1146/annurev-immunol-032712-100001. Epub 2013 Jan 3. Review.

PMID:
23298212
16.

FAO-OIE-WHO Joint Technical Consultation on Avian Influenza at the Human-Animal Interface.

Anderson T, Capua I, Dauphin G, Donis R, Fouchier R, Mumford E, Peiris M, Swayne D, Thiermann A.

Influenza Other Respir Viruses. 2010 May;4 Suppl 1:1-29. doi: 10.1111/j.1750-2659.2009.00114.x.

17.

Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants.

Deming D, Sheahan T, Heise M, Yount B, Davis N, Sims A, Suthar M, Harkema J, Whitmore A, Pickles R, West A, Donaldson E, Curtis K, Johnston R, Baric R.

PLoS Med. 2006 Dec;3(12):e525. Erratum in: PLoS Med. 2007 Feb;4(2):e80.

18.

Mismatched double-stranded RNA: polyI:polyC12U.

[No authors listed]

Drugs R D. 2004;5(5):297-304.

PMID:
15357629
19.

Influenza as a model system for studying the cross-species transfer and evolution of the SARS coronavirus.

Bush RM.

Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1067-73. Review.

20.

Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine.

Tsunetsugu-Yokota Y, Ohnishi K, Takemori T.

Rev Med Virol. 2006 Mar-Apr;16(2):117-31. Review.

PMID:
16518829

Supplemental Content

Support Center